Generic name: lamivudine and zidovudine, sometimes also called 3TC and AZT respectively.
Lamivudine / zidovudine is available as a generic medicine, so its appearance will depend on which type your clinic buys.
Brand names: Combivir (the image on this page is of the version of lamivudine and zidovudine combination which has the brand name Combivir)
Class: Combined NRTI (nukes) tablets
Very common (affecting more than 1 in 10 people): Headache, nausea. Common (affecting up to 1 in 10 people): Headache, nausea, vomiting, stomach pain, appetite loss, diarrhoea, fever, insomnia, tiredness, joint pain, rash, cough, alopecia, dizziness, feeling unwell, muscle pain, runny nose, anaemia, low white blood cell count (neutropenia or leucopenia), increase in liver enzymes, increased levels of bilirubin. Uncommon (affecting up to 1 in 100 people): Itching, flatulence, muscle weakness, feeling breathless, thrombocytopenia (decreased levels of cells involved in blood clotting). Decrease in all kinds of blood cells (pancytopenia).
Tablet comprises 150mg lamivudine and 300mg zidovudine.Take one tablet twice a day.
Take with or without food.
Combivir is no longer recommended as a first choice of treatment for those starting treatment in the UK or USA.
*Last reviewed on 19/12/2016 Next review: 19/12/2019
Any questions? Email firstname.lastname@example.org Information included on this website was correct at the time of publication.
Data and image supplied by NAM.
Various people talk about their experiences of living with HIV.
CAB - Citizens Advice Bureau
HIV Drug Interactions
George House Trust
Equality and Human Rights Commission
Copyright 2018 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527)
Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 314-320 Gray's Inn Road, London, WC1X 8DP.